Quince Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Quince Therapeutics, Inc. (QNCX) reported Basic Shares Outstanding (Weighted Average) of 6.13 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- Quince Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 6.13M shares, a 2527.26% increase year-over-year.
- Quince Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 9.12M shares, a 107.56% increase year-over-year.
- Quince Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 55.68M shares, a 27.20% increase year-over-year.
- Quince Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 53.95M shares, a 24.99% increase year-over-year.
- Quince Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 50.10M shares, a 15.80% increase from fiscal 2024.
- Quince Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 43.26M shares, a 16.18% increase from fiscal 2023.
- Quince Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 37.24M shares, a 11.17% increase from fiscal 2022.
- Quince Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 33.50M shares, a 12.71% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 6.13M shares 10-Q · filed 2026-08-14 | 3.30M shares 10-Q · filed 2026-08-14 | 23.65M shares derived: average of 3 quarters · filed 2026-08-14 | 31.22M shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | 9.12M shares 10-Q · filed 2026-05-11 | 32.40M shares derived: average of 2 quarters · filed 2026-05-11 | 39.59M shares derived: average of 3 quarters · filed 2026-05-11 | 29.75M shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | 55.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | 54.82M shares derived: average of 2 quarters · filed 2026-04-10 | 36.62M shares derived: average of 3 quarters · filed 2026-08-14 | 50.10M shares 10-K · filed 2026-04-10 | ||
| 2025-09-30 | 53.95M shares 10-Q · filed 2025-11-12 | 27.09M shares derived: average of 2 quarters · filed 2026-08-14 | 48.23M shares 10-Q · filed 2025-11-12 | 25.59M shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | 233.43K shares 10-Q · filed 2026-08-14 | 46.69M shares 10-Q · filed 2025-08-11 | 226.57K shares 10-Q · filed 2026-08-14 | 45.31M shares 10-Q · filed 2025-08-11 | 16.13M shares derived: average of 3 quarters · filed 2026-08-14 | 22.89M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | 4.39M shares 10-Q · filed 2026-05-11 | 43.94M shares 10-Q · filed 2025-05-13 | 24.09M shares derived: average of 2 quarters · filed 2026-05-11 | 30.45M shares derived: average of 3 quarters · filed 2026-05-11 | 33.61M shares derived: average of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | 43.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | 43.47M shares derived: average of 2 quarters · filed 2026-04-10 | 43.35M shares derived: average of 3 quarters · filed 2026-04-10 | 43.26M shares 10-K · filed 2026-04-10 | ||
| 2024-09-30 | 43.16M shares 10-Q · filed 2025-11-12 | 43.13M shares derived: average of 2 quarters · filed 2025-11-12 | 43.09M shares 10-Q · filed 2025-11-12 | 42.60M shares derived: average of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | 43.10M shares 10-Q · filed 2025-08-11 | 43.05M shares 10-Q · filed 2025-08-11 | 42.41M shares derived: average of 3 quarters · filed 2025-08-11 | 40.83M shares derived: average of 4 quarters · filed 2025-08-11 | ||
| 2024-03-31 | 43.01M shares 10-Q · filed 2025-05-13 | 42.07M shares derived: average of 2 quarters · filed 2025-05-13 | 40.07M shares derived: average of 3 quarters · filed 2025-05-13 | 39.03M shares derived: average of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | 41.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | 38.60M shares derived: average of 2 quarters · filed 2025-03-24 | 37.71M shares derived: average of 3 quarters · filed 2025-03-24 | 37.24M shares 10-K · filed 2025-03-24 | ||
| 2023-09-30 | 36.07M shares 10-Q · filed 2024-11-13 | 36.00M shares derived: average of 2 quarters · filed 2024-11-13 | 35.94M shares 10-Q · filed 2024-11-13 | 35.89M shares derived: average of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | 35.92M shares 10-Q · filed 2024-08-13 | 35.89M shares 10-Q · filed 2024-08-13 | 35.83M shares derived: average of 3 quarters · filed 2024-08-13 | 35.77M shares derived: average of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | 35.86M shares 10-Q · filed 2024-05-13 | 35.78M shares derived: average of 2 quarters · filed 2024-05-13 | 35.73M shares derived: average of 3 quarters · filed 2024-05-13 | 34.91M shares derived: average of 4 quarters · filed 2024-05-13 | ||
| 2022-12-31 | 35.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 35.66M shares derived: average of 2 quarters · filed 2024-04-01 | 34.60M shares derived: average of 3 quarters · filed 2024-04-01 | 33.50M shares 10-K · filed 2024-04-01 | ||
| 2022-09-30 | 35.61M shares 10-Q · filed 2023-11-14 | 34.04M shares derived: average of 2 quarters · filed 2023-11-14 | 32.76M shares 10-Q · filed 2023-11-14 | 32.04M shares derived: average of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | 32.47M shares 10-Q · filed 2023-08-03 | 31.31M shares 10-Q · filed 2023-08-03 | 30.85M shares derived: average of 3 quarters · filed 2023-08-03 | 30.58M shares derived: average of 4 quarters · filed 2023-08-03 | ||
| 2022-03-31 | 30.13M shares 10-Q · filed 2023-05-15 | 30.05M shares derived: average of 2 quarters · filed 2023-05-15 | 29.95M shares derived: average of 3 quarters · filed 2023-05-15 | 29.86M shares derived: average of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | 29.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | 29.86M shares derived: average of 2 quarters · filed 2023-03-15 | 29.77M shares derived: average of 3 quarters · filed 2023-03-15 | 29.72M shares 10-K · filed 2023-03-15 | ||
| 2021-09-30 | 29.77M shares 10-Q · filed 2022-11-09 | 29.68M shares derived: average of 2 quarters · filed 2022-11-09 | 29.64M shares 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | 29.59M shares 10-Q · filed 2022-08-09 | 29.57M shares 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |